Skip to content

Development and Validation of a Nutritional Management Pathway and a Feeding Intolerance Risk Prediction Model for Patients with Severe Pneumonia

Development and Validation of a Nutritional Management Pathway and a Feeding Intolerance Risk Prediction Model for Patients with Severe Pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109831
Enrollment
Unknown
Registered
2025-09-25
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe pneumonia

Interventions

Enteral nutrition intolerance group:This is a retrospective observational study where no intervention was applied. Patients in this group developed feeding intolerance during enteral nutrition support
Enteral nutrition tolerance group:This is a retrospective observational study in which no interventions are imposed. Patients in this group did not develop feeding intolerance during enteral nutrition

Sponsors

Rizhao People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.The main diagnosis at admission is "severe pneumonia" 2.All patients have undergone nutritional risk screening, and nutritional support has been provided for those at high risk 3.The duration of nutritional support is more than 7 days 4. The reimbursement method is 'medical insurance'.

Exclusion criteria

Exclusion criteria: 1. Aged 90 years 2.Patients with severe mental illness, shock, or brain death 3.Patients with intestinal infection, severe digestive system diseases, or those who have undergone abdominal surgery 4.Patients with severe liver or kidney failure 5.Patients with other severe diseases such as advanced tumors, pregnancy, hematological diseases, or thyroid diseases 6.Patients who have received nutritional support before being admitted to the ICU 7.Patients who have used prokinetic drugs or taken probiotics before enteral nutrition 8. Incomplete clinical data or families giving up treatment midway 9. Albumin <= 25mg/L upon admission to the ICU; 10. Incomplete clinical data or family abandons treatment midway.

Design outcomes

Primary

MeasureTime frame
28-Day All-Cause Mortality;Nutrition Compliance Rate;Overall Survival;

Secondary

MeasureTime frame
Serum Albumin;Enteral Nutrition Intolerance Rate;

Countries

China

Contacts

Public Contactchen yao

Rizhao People's Hospital, Shandong Province

754332435@qq.com+86 183 6338 1630

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026